Product Wiki · Recalls · U.S. CPSC

Recall 22060 — Over-the-counter drugs

U.S. CPSC · United States · 2022-01-26

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →
Agency
U.S. CPSC
Recall identifier
22060
Date of alert
2022-01-26
Country / jurisdiction
United States
Risk type
recall
Brand
Geri-Care Pharmaceuticals, of Brooklyn, New York
Product category
consumer_product
Reported risk: This recall involves bottles of Geri-Care Brand over-the-counter acetaminophen and aspirin. The acetaminophen is 500mg with 1,000 tablets in the bottle. The aspirin was sold in 81mg with 300 and 1,000 tablets in the bottle and 325mg with 250 and 1,000 tablets in the bottle. Product Count Extra Strength Acetaminophen 500mg Tablets 1,000 Regular Strength Enteric Coated Aspirin 325mg Tablets 250 Regular Strength Enteric Coated Aspirin 325mg Tablets 1,000 Adult Low Dose Enteric Coated Aspirin 81mg Tablets 300 Adult Low Dose Enteric Coated Aspirin 81mg Tablets 1,000 Hazards: The over-the-counter drug products contain regulated substances which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Primary source: https://www.cpsc.gov/Recalls/2022/Geri-Care-Pharmaceuticals-Recalls-Over-the-Cou

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.